Clinical Study

Chemotherapy Administration during Pelvic Radiation for Cervical Cancer Patients Aged ≥ 55 Years in the SEER-Medicare Population

Table 3

Univariate comparison of patients who received chemoradiation treatment versus those who received radiation treatment alone.

Chemoradiation ( )RT alone ( ) value*

Age <.001

Stage.393
II89 (53.6%)124 (56.6%)
III74 (44.6%)89 (40.6%)
IVA3 (1.8%)6 (2.7%)

Histology.628
Squamous129 (77.7%)160 (73.1%)
Adenocarcinoma23 (13.8%)32 (14.6%)
Adenosquamous4 (2.4%)9 (4.1%)
Other10 (6.0%)18 (8.2%)

Race.445
Caucasian97 (58.4%)140 (63.9%)
African-American34 (20.5%)40 (18.3%)
Hispanic6 (3.6%)9 (4.1%)
Asian14 (8.4%)20 (9.1%)
Other15 (9.0%)10 (4.6%)

Location.028
Big metropolitan (≥250,000)88 (53.0%)147 (67.1%)
Metropolitan (20,000 to 249,999)44 (26.5%)50 (22.8%)
Urban (2,500–19,999, adjacent metro area)11 (6.6%)6 (2.7%)
Less urban (2,500–19,999, not adjacent metro area)19 (11.4%)13 (5.9%)
Rural (<2,500)4 (2.4%)3 (1.4%)

Socioeconomic status (median income per census tract)$44,308 ± $1,512$44,715 ± $1,614.858

Comorbidity index, Charlson.641
0116 (69.9%)158 (72.1%)
131 (18.7%)32 (14.6%)
210 (6.0%)18 (8.2%)
3+9 (5.4%)11 (5.0%)

*Student's t-test or chi-square for frequency data.